{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:59:25Z","timestamp":1777651165942,"version":"3.51.4"},"reference-count":76,"publisher":"Georg Thieme Verlag KG","issue":"03","funder":[{"name":"National Institute of Health","award":["HL 128859"],"award-info":[{"award-number":["HL 128859"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Invasive fungal infections threaten lung transplant outcomes with high associated morbidity and mortality. Pharmacologic prophylaxis may be key to prevent posttransplant invasive fungal infections, but cost, adverse effects, and absorption issues are barriers to effective prophylaxis. Trends in fungal infection diagnostic strategies utilize molecular diagnostic methodologies to complement traditional histopathology and culture techniques. While lung transplant recipients are susceptible to a variety of fungal pathogens, Candida spp. and Aspergillus spp. infections remain the most common. With emerging resistant organisms and multiple novel antifungal agents in the research pipeline, it is likely that treatment strategies will continue to evolve.<\/jats:p>","DOI":"10.1055\/s-0041-1729173","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T22:33:35Z","timestamp":1621895615000},"page":"471-482","source":"Crossref","is-referenced-by-count":14,"title":["Fungal Infection in Lung Transplantation"],"prefix":"10.1055","volume":"42","author":[{"given":"Cassie C.","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota"},{"name":"William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly M.","family":"Pennington","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota"},{"name":"William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Beam","sequence":"additional","affiliation":[{"name":"William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, Minnesota"},{"name":"Division of Infectious Disease, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymund R.","family":"Razonable","sequence":"additional","affiliation":[{"name":"William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, Minnesota"},{"name":"Division of Infectious Disease, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2021,5,24]]},"reference":[{"issue":"03","key":"ref1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1399-0012.2009.01076.x","article-title":"The impact of invasive fungal diseases on survival after lung transplantation","volume":"24","author":"S K Arthurs","year":"2010","journal-title":"Clin Transplant"},{"issue":"06","key":"ref2","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11908-013-0380-y","article-title":"Anti-Aspergillus prophylaxis in lung transplantation: a systematic review and meta-analysis","volume":"15","author":"A Bhaskaran","year":"2013","journal-title":"Curr Infect Dis Rep"},{"issue":"09","key":"ref3","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/myc.12960","article-title":"Defining breakthrough invasive fungal infection\u2014position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology","volume":"62","author":"O A Cornely","year":"2019","journal-title":"Mycoses"},{"issue":"06","key":"ref4","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/ajt.12691","article-title":"Epidemiology of invasive mold infections in lung transplant recipients","volume":"14","author":"C T Doligalski","year":"2014","journal-title":"Am J Transplant"},{"issue":"02","key":"ref5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/tid.12362","article-title":"Invasive mold infections in lung and heart-lung transplant recipients: Stanford University experience","volume":"17","author":"R Vazquez","year":"2015","journal-title":"Transpl Infect Dis"},{"issue":"05","key":"ref6","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s11046-020-00431-2","article-title":"Re-drawing the maps for endemic mycoses","volume":"185","author":"N Ashraf","year":"2020","journal-title":"Mycopathologia"},{"issue":"03","key":"ref7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1128\/JCM.01661-19","article-title":"Human blastomycosis in South Africa caused by Blastomyces percursus and Blastomyces emzantsi sp. nov., 1967 to 2014","volume":"58","author":"T G Maphanga","year":"2020","journal-title":"J Clin Microbiol"},{"issue":"03","key":"ref8","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3201\/eid2603.191536","article-title":"Suspected locally acquired coccidioidomycosis in human, Spokane, Washington, USA","volume":"26","author":"H N Oltean","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"07","key":"ref9","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.3201\/eid2607.200088","article-title":"Paradoxal trends in azole-resistant Aspergillus fumigatus in a national multicenter surveillance program, the Netherlands, 2013-2018","volume":"26","author":"P PA Lestrade","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"02","key":"ref10","doi-asserted-by":"crossref","first-page":"e02295","DOI":"10.1128\/AEM.02295-20","article-title":"Dynamics of Aspergillus fumigatus in azole fungicide-containing plant waste in the Netherlands (2016-2017)","volume":"87","author":"J Zhang","year":"2021","journal-title":"Appl Environ Microbiol"},{"issue":"10","key":"ref11","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1128\/JCM.00854-09","article-title":"Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network","volume":"47","author":"J W Baddley","year":"2009","journal-title":"J Clin Microbiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"106019","DOI":"10.1016\/j.rmed.2020.106019","article-title":"Pneumocystis pneumonia after lung transplantation: a retrospective multicenter study","volume":"169","author":"A Delbove","year":"2020","journal-title":"Respir Med"},{"issue":"02","key":"ref13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-6143.2010.03375.x","article-title":"Antifungal prophylaxis in lung transplantation--a world-wide survey","volume":"11","author":"C F Neoh","year":"2011","journal-title":"Am J Transplant"},{"issue":"07","key":"ref14","doi-asserted-by":"crossref","first-page":"e13630","DOI":"10.1111\/ctr.13630","article-title":"Antifungal prophylaxis in lung transplant: a survey of United States' transplant centers","volume":"33","author":"K M Pennington","year":"2019","journal-title":"Clin Transplant"},{"issue":"04","key":"ref15","doi-asserted-by":"crossref","first-page":"e13333","DOI":"10.1111\/tid.13333","article-title":"Antifungal prophylaxis in lung transplant recipients: a systematic review and meta-analysis","volume":"22","author":"K M Pennington","year":"2020","journal-title":"Transpl Infect Dis"},{"issue":"03","key":"ref16","doi-asserted-by":"crossref","first-page":"e13067","DOI":"10.1111\/tid.13067","article-title":"Why do lung transplant patients discontinue triazole prophylaxis?","volume":"21","author":"K M Pennington","year":"2019","journal-title":"Transpl Infect Dis"},{"issue":"03","key":"ref17","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1513\/AnnalsATS.202003-267OC","article-title":"The impact of antifungal prophylaxis in lung transplant recipients","volume":"18","author":"K M Pennington","year":"2021","journal-title":"Ann Am Thorac Soc"},{"issue":"04","key":"ref18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/tid.12071","article-title":"Preemptive treatment with voriconazole in lung transplant recipients","volume":"15","author":"C F Neoh","year":"2013","journal-title":"Transpl Infect Dis"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/ctr.12854","article-title":"Is universal antifungal prophylaxis mandatory in adults after lung transplantation? A review and meta-analysis of observational studies","volume":"30","author":"K Pilarczyk","year":"2016","journal-title":"Clin Transplant"},{"issue":"06","key":"ref20","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s15010-017-1072-6","article-title":"Diagnosing filamentous fungal infections in immunocompromised patients applying computed tomography-guided percutaneous lung biopsies: a 12-year experience","volume":"45","author":"C Lass-Fl\u00f6rl","year":"2017","journal-title":"Infection"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1128\/JCM.43.10.5214-5220.2005","article-title":"Detection of Aspergillus galactomannan antigenemia to determine biological and clinical implications of beta-lactam treatments","volume":"43","author":"E Bart-Delabesse","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"S 01","key":"ref22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1470-9465.2004.00847.x","article-title":"Antifungal prophylaxis with azole derivatives","volume":"10","author":"E Castagnola","year":"2004","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/503427","article-title":"Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis","volume":"42","author":"C D Pfeiffer","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"06","key":"ref24","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jinf.2010.08.014","article-title":"Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis","volume":"61","author":"S Y Park","year":"2010","journal-title":"J Infect"},{"issue":"02","key":"ref25","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1378\/chest.09-0701","article-title":"Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies","volume":"137","author":"A Bergeron","year":"2010","journal-title":"Chest"},{"issue":"04","key":"ref26","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1378\/chest.10-0488","article-title":"Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review","volume":"138","author":"Y L Guo","year":"2010","journal-title":"Chest"},{"issue":"01","key":"ref27","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3109\/1040841X.2013.804033","article-title":"Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis","volume":"41","author":"S C Heng","year":"2015","journal-title":"Crit Rev Microbiol"},{"issue":"02","key":"ref28","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.diagmicrobio.2010.03.017","article-title":"Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies","volume":"68","author":"M L Luong","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"12","key":"ref29","doi-asserted-by":"crossref","first-page":"e874","DOI":"10.1016\/j.ijid.2011.09.011","article-title":"Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance","volume":"15","author":"Z Racil","year":"2011","journal-title":"Int J Infect Dis"},{"issue":"01","key":"ref30","doi-asserted-by":"crossref","first-page":"e87784","DOI":"10.1371\/journal.pone.0087784","article-title":"Earlier diagnosis of invasive fusariosis with Aspergillus serum galactomannan testing","volume":"9","author":"M Nucci","year":"2014","journal-title":"PLoS One"},{"issue":"05","key":"ref31","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.transproceed.2006.02.072","article-title":"Usefulness of sequential Aspergillus galactomannan antigen detection combined with early radiologic evaluation for diagnosis of invasive pulmonary aspergillosis in patients undergoing allogeneic stem cell transplantation","volume":"38","author":"A Busca","year":"2006","journal-title":"Transplant Proc"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0140-6736(95)91152-9","article-title":"Plasma (1-->3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes","volume":"345","author":"T Obayashi","year":"1995","journal-title":"Lancet"},{"issue":"12","key":"ref33","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1513\/AnnalsATS.201908-582CME","article-title":"Summary for clinicians: microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice","volume":"16","author":"C A Hage","year":"2019","journal-title":"Ann Am Thorac Soc"},{"issue":"05","key":"ref34","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4103\/ijccm.IJCCM_4_18","article-title":"Experience with \u03b2-D-glucan assay in the management of critically ill patients with high risk of invasive candidiasis: an observational study","volume":"22","author":"N Bansal","year":"2018","journal-title":"Indian J Crit Care Med"},{"issue":"08","key":"ref35","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1093\/jac\/dkw112","article-title":"(1,3)-\u03b2-D-glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study","volume":"71","author":"B Posteraro","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"02","key":"ref36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5858\/arpa.2014-0230-RS","article-title":"Application of the 1,3-\u03b2-D-glucan (Fungitell) assay in the diagnosis of invasive fungal infections","volume":"140","author":"T Tran","year":"2016","journal-title":"Arch Pathol Lab Med"},{"issue":"06","key":"ref37","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/QAD.0b013e32835cb646","article-title":"Test performance of blood beta-glucan for Pneumocystis jirovecii pneumonia in patients with AIDS and respiratory symptoms","volume":"27","author":"B R Wood","year":"2013","journal-title":"AIDS"},{"key":"ref38","first-page":"CD009551","article-title":"Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people","author":"M Cruciani","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"03","key":"ref39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1099\/jmm.0.000218","article-title":"Development and application of two independent real-time PCR assays to detect clinically relevant Mucorales species","volume":"65","author":"J Springer","year":"2016","journal-title":"J Med Microbiol"},{"issue":"11","key":"ref40","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1128\/JCM.00942-12","article-title":"Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review","volume":"50","author":"T Avni","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"182","key":"ref41","doi-asserted-by":"crossref","first-page":"182ra54","DOI":"10.1126\/scitranslmed.3005377","article-title":"T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood","volume":"5","author":"L A Neely","year":"2013","journal-title":"Sci Transl Med"},{"issue":"06","key":"ref42","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/cid\/ciu959","article-title":"T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial","volume":"60","author":"E Mylonakis","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"05","key":"ref43","doi-asserted-by":"crossref","first-page":"e01909","DOI":"10.1128\/JCM.01909-17","article-title":"Diagnosing invasive candidiasis","volume":"56","author":"C J Clancy","year":"2018","journal-title":"J Clin Microbiol"},{"issue":"03","key":"ref44","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1128\/JCM.02971-15","article-title":"Cost-effectiveness analysis of multiplex PCR with magnetic resonance detection versus empiric or blood culture-directed therapy for management of suspected candidemia","volume":"54","author":"B Walker","year":"2016","journal-title":"J Clin Microbiol"},{"issue":"10","key":"ref45","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1128\/JCM.42.10.4873-4875.2004","article-title":"Antigen assay with the potential to aid in diagnosis of blastomycosis","volume":"42","author":"M Durkin","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"02","key":"ref46","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.diagmicrobio.2010.09.015","article-title":"Detection of Blastomyces dermatitidis antigen in patients with newly diagnosed blastomycosis","volume":"69","author":"J R Bariola","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"11","key":"ref47","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1128\/JCM.02352-15","article-title":"Blastomyces antigen detection for diagnosis and management of blastomycosis","volume":"53","author":"H M Frost","year":"2015","journal-title":"J Clin Microbiol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11046-015-9965-3","article-title":"Antigen Detection in the Diagnosis of Histoplasmosis: A Meta-analysis of Diagnostic Performance","volume":"181","author":"E Fandi\u00f1o-Devia","year":"2016","journal-title":"Mycopathologia"},{"issue":"07","key":"ref49","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/cid\/ciw007","article-title":"Improved diagnosis of acute pulmonary histoplasmosis by combining antigen and antibody detection","volume":"62","author":"S M Richer","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"09","key":"ref50","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJM198602273140901","article-title":"Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin","volume":"314","author":"B S Klein","year":"1986","journal-title":"N Engl J Med"},{"issue":"02","key":"ref51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1128\/CVI.00597-13","article-title":"Development of a highly sensitive and specific blastomycosis antibody enzyme immunoassay using Blastomyces dermatitidis surface protein BAD-1","volume":"21","author":"S M Richer","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"03","key":"ref52","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1128\/JCM.01880-16","article-title":"Enhanced antibody detection and diagnosis of coccidioidomycosis with the Miravista IgG and IgM detection enzyme immunoassay","volume":"55","author":"J Malo","year":"2017","journal-title":"J Clin Microbiol"},{"issue":"09","key":"ref53","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00134-014-3408-3","article-title":"Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010)","volume":"40","author":"O Lortholary","year":"2014","journal-title":"Intensive Care Med"},{"issue":"08","key":"ref54","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/cid\/cis021","article-title":"Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials","volume":"54","author":"D R Andes","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"07","key":"ref55","first-page":"986","article-title":"Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003)","volume":"91","author":"G Chamilos","year":"2006","journal-title":"Haematologica"},{"issue":"01","key":"ref56","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/MD.0b013e318207612d","article-title":"Fusarium infection in lung transplant patients: report of 6 cases and review of the literature","volume":"90","author":"H A Carneiro","year":"2011","journal-title":"Medicine (Baltimore)"},{"issue":"05","key":"ref57","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"M M Roden","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"01","key":"ref58","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/tid.12166","article-title":"Reverse halo sign on chest imaging in a renal transplant recipient","volume":"16","author":"J I Stewart","year":"2014","journal-title":"Transpl Infect Dis"},{"issue":"02","key":"ref59","doi-asserted-by":"crossref","first-page":"e13774","DOI":"10.1111\/ctr.13774","article-title":"Mucormycosis in lung transplant recipients: a systematic review of the literature and a case series","volume":"34","author":"O Wand","year":"2020","journal-title":"Clin Transplant"},{"issue":"05","key":"ref60","doi-asserted-by":"crossref","first-page":"e13163","DOI":"10.1111\/tid.13163","article-title":"The use of genome sequencing to investigate an outbreak of hospital-acquired mucormycosis in transplant patients","volume":"21","author":"C Marek","year":"2019","journal-title":"Transpl Infect Dis"},{"issue":"12","key":"ref61","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.ajic.2016.06.017","article-title":"Control of an outbreak of postoperative bone mucormycosis: an intervention study of contiguous cohorts","volume":"44","author":"M S Chaves","year":"2016","journal-title":"Am J Infect Control"},{"issue":"05","key":"ref62","first-page":"765","article-title":"Outbreaks of Mucorales and the species involved","volume":"185","author":"G Walther","year":"2020","journal-title":"Mycopathologia"},{"issue":"01","key":"ref63","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/rccm.2008-740ST","article-title":"An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients","volume":"183","author":"A H Limper","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"09","key":"ref64","doi-asserted-by":"crossref","first-page":"e13553","DOI":"10.1111\/ctr.13553","article-title":"Endemic fungal infections in solid organ transplant recipients-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"R Miller","year":"2019","journal-title":"Clin Transplant"},{"issue":"02","key":"ref65","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/tid.12186","article-title":"Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"16","author":"C A Kauffman","year":"2014","journal-title":"Transpl Infect Dis"},{"issue":"24","key":"ref66","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia","volume":"350","author":"C F Thomas Jr","year":"2004","journal-title":"N Engl J Med"},{"issue":"12","key":"ref67","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1177\/0885066619834242","article-title":"Preadmission corticosteroid therapy and the risk of respiratory failure in adults without HIV presenting with Pneumocystis pneumonia","volume":"35","author":"P M Wieruszewski","year":"2020","journal-title":"J Intensive Care Med"},{"issue":"10","key":"ref68","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1093\/jac\/dkz303","article-title":"Clinical experience with new formulation SUBA\u00ae-itraconazole for prophylaxis in patients undergoing stem cell transplantation or treatment for haematological malignancies","volume":"74","author":"B Nield","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"S 03","key":"ref69","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1093\/infdis\/jiaa394","article-title":"Core recommendations for antifungal stewardship: a statement of the Mycoses Study Group Education and Research Consortium","volume":"222","author":"M D Johnson","year":"2020","journal-title":"J Infect Dis"},{"issue":"04","key":"ref70","first-page":"6","article-title":"Fosmanogepix: a review of the first-in-class broad spectrum agent for the treatment of invasive fungal infections","volume":"6","author":"K J Shaw","year":"2020","journal-title":"J Fungi (Basel)"},{"issue":"01","key":"ref71","first-page":"65","article-title":"Olorofim susceptibility testing of 1,423 Danish mold isolates obtained in 2018-2019 confirms uniform and broad-spectrum activity","volume":"65","author":"K MT Astvad","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"ref72","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1093\/jac\/dkaa351","article-title":"In vitro activity of olorofim against clinical isolates of Scedosporium species and Lomentospora prolificans using EUCAST and CLSI methodologies","volume":"75","author":"O Rivero-Menendez","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"ref73","first-page":"dkaa562","article-title":"In vitro activity of the novel antifungal olorofim against dermatophytes and opportunistic moulds including Penicillium and Talaromyces species","author":"A Singh","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"ciaa1204","DOI":"10.1093\/cid\/ciaa1204","article-title":"Randomized phase 2 study of VT-1161 for the treatment of acute vulvovaginal candidiasis","author":"S R Brand","year":"2020","journal-title":"Clin Infect Dis"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"ciaa1380","DOI":"10.1093\/cid\/ciaa1380","article-title":"Rezafungin versus caspofungin in a phase 2, randomized, double-blind study for the treatment of candidemia and invasive candidiasis\u2014The STRIVE trial","author":"G R Thompson","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"03","key":"ref76","doi-asserted-by":"crossref","first-page":"e01992-20","DOI":"10.1128\/AAC.01992-20","article-title":"Efficacy of rezafungin in prophylactic mouse models of invasive Candidiasis, Aspergillosis, and Pneumocystis pneumonia","volume":"65","author":"L Miesel","year":"2021","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1729173.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T03:33:57Z","timestamp":1699068837000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1729173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,24]]},"references-count":76,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2021,5,24]]},"published-print":{"date-parts":[[2021,6]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1729173","relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,24]]}}}